GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7KEI | 7KEI | DQA1*01:02/DQB1*06:02 in complex with a hemagglutinin peptide from the H1N1 pandemic flu virus. | |
7KDU | 7KDU | Ricin bound to VHH antibody V5E4 | |
7KDM | 7KDM | Ricin bound to VHH antibody V5G6 | |
7KDE | 7KDE | BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein gp120, Ab 1485 Heavy Chain, Ab 1485 Light Chain, 8ANC195 Fab Heavy Chain, 8ANC195 Fab Light Chain |
7KDD | 7KDD | HCMV postfusion gB in complex with SM5-1 Fab | Envelope glycoprotein B, SM5-1 Fab antibody heavy chain, SM5-1 Fab antibody light chain |
7KD6 | 7KD6 | Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b | |
7KD2 | 7KD2 | Ricin bound to VHH antibody V11B2 | |
7KD0 | 7KD0 | Ricin bound to VHH antibody V2C11 | |
7KCR | 7KCR | Cryo-EM structure of Zika virus in complex with E protein cross-linking human monoclonal antibody ADI30056 | ADI30056 mAb heavy chain, ADI30056 mAb light chain, envelope protein E, membrane protein M |
7KC9 | 7KC9 | Ricin bound to VHH antibody V5G1 | |
7KC1 | 7KC1 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
7KBT | 7KBT | Factor VIII in complex with the anti-C2 domain antibody, G99 | |
7KBK | 7KBK | Ricin bound to VHH antibody V6E11 | |
7KBI | 7KBI | Ricin bound to VHH antibody V5E1 | |
7K9Z | 7K9Z | Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52 | |
7K9K | 7K9K | SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement) | |
7K9J | 7K9J | SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation) | |
7K9I | 7K9I | SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2B04 (local refinement) | |
7K9H | 7K9H | SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation) | |
7K93 | 7K93 | DENV2 NS1 in complex with neutralizing 2B7 single chain Fab variable region (scFv) | |
7K90 | 7K90 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144 | Spike glycoprotein, C144 Fab Heavy Chain, C144 Fab Light Chain |
7K8Z | 7K8Z | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135 | Spike glycoprotein, C135 Fab Light Chain, C135 Fab Heavy Chain |
7K8Y | 7K8Y | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2) | Spike glycoprotein, C121 Fab Heavy chain, C121 Fab Light chain |
7K8X | 7K8X | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1) | Spike glycoprotein, C121 Fab Heavy chain, C121 Fab Light chain |
7K8W | 7K8W | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119 | Spike glycoprotein, C119 Fab Light Chain, C119 Fab Heavy Chain |
7K8V | 7K8V | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110 | Spike glycoprotein, C110 Fab Heavy Chain, C110 Fab Light Chain |
7K8U | 7K8U | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104 | Spike glycoprotein, C104 Fab Heavy Chain, C104 Fab Light Chain |
7K8T | 7K8T | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2) | Spike glycoprotein, C002 Fab Heavy Chain, C002 Fab Light Chain |
7K8S | 7K8S | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1) | Spike glycoprotein, C002 Fab Heavy Chain, C002 Fab Light Chain |
7K8M | 7K8M | Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102 | |
7K81 | 7K81 | KIR3DL1*005 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide | |
7K80 | 7K80 | KIR3DL1*001 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide | |
7K66 | 7K66 | Structure of Blood Coagulation Factor VIII in Complex with an Anti-C1 Domain Pathogenic Antibody Inhibitor | |
7K65 | 7K65 | Hedgehog receptor Patched (PTCH1) in complex with conformation selective nanobody TI23 | Protein patched homolog 1, nanobody TI23 |
7K4N | 7K4N | SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment | Spike glycoprotein, S2E12 neutralizing antibody Fab fragment (heavy chain), S2E12 neutralizing antibody Fab fragment (light chain) |
7K45 | 7K45 | SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains) | |
7K43 | 7K43 | SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2M11 Fab fragment (heavy chain), S2M11 Fab fragment (light chain) |
7K3B | 7K3B | Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation C, central helices splay | Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain |
7K3A | 7K3A | Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation B, fusion peptide release | Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain |
7K39 | 7K39 | Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation A, neutral pH-like | Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain |
7K37 | 7K37 | Structure of full-length influenza HA with a head-binding antibody at pH 7.8 | Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain |
7K0Z | 7K0Z | Marsupial T cell receptor Spl_157 | |
7K0X | 7K0X | Marsupial T cell receptor Spl_145 | |
7JZU | 7JZU | SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) | LCB1,Spike glycoprotein |
7JZN | 7JZN | SARS-CoV-2 spike in complex with LCB3 (2RBDs open) | Spike glycoprotein,LCB3 |
7JZM | 7JZM | SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) | LCB3,spike glycoprotein |
7JZL | 7JZL | SARS-CoV-2 spike in complex with LCB1 (2RBDs open) | Spike glycoprotein,LCB1 |
7JZK | 7JZK | Crystal structure of LAIR1 ectodomain (from MGD21) in complex with Plasmodium RIFIN (PF3D7_0401300) V2 domain | |
7JZ4 | 7JZ4 | Crystal structure of broadly Plasmodium RIFIN reactive LAIR1-inserted antibody MGD21 | |
7JX3 | 7JX3 | Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024